Saleh Hamieh is from Taraya, Bekaa Governate, Lebanon.
He first started his university studies in Saint Joseph University (USJ) -Beirut in Laboratory and Medical Analysis. After, he switched to study Chemistry at Lebanese University (UL) in Beirut where he received a BSc. degree in General Chemistry. Saleh joined later Pr. Myriam-Malet Martino head of SPCMIB Laboratory (Synthèse des Molecules d'Intérêts Biologiques) in Paul Sabatier University (UPS) – Toulouse, France, for a nice-months training research. In 2007 he obtained a MSc. Degree in Biological Chemistry (Chimie-Biologie) from the same University. His Master research project prepared in Laboratoire de Chimie de Coordination at CNRS, concerned the synthesis of a new anti-tuberculosis agent. Saleh later prepared an internship of 5 months at ECPM (Ecole de Chimie, Materiaux et Polymers) Strasbourg-France in LPCB laboratory (Laboratoire de Physico-Chimie Bioinorganique) dealing with complexation of pyoverdine by biological interest metals. He worked after for Ameeron Company in KSA, Khobar. In September 2008, Saleh joined the research group of Dr. Sijbren Otto to start a PhD funded by Marie Curie Actions. In his PhD studies, Saleh is mainly working on water soluble receptors for small bio-active molecules such as nicotine, a diamine that acts as a potent agonist of the nicotinic acetylcholine receptor α4β2 in the brain. He is also working on data mining techniques aimed to assess molecular similarity using Dynamic Combinatorial libraries.